Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaffer Ajani

Showing results (51-60 of 110) with videos related to

Pageof 11
Sort By:
Annals of Surgical Oncology|March 24, 2017
Patterns of Initial Recurrence in Gastric Adenocarcinoma in the Era of Preoperative TherapyNaruhiko Ikoma, Hsiang-Chun Chen, Xuemei Wang, et al.
International Journal of Radiation Oncology, Biology, Physics|June 16, 2009
Induction and concurrent taxanes enhance both the pulmonary metabolic radiation response and the radiation pneumonitis response in patients with esophagus cancerMatthew McCurdy, Mary Frances McAleer, Wei Wei, et al.
The Annals of Thoracic Surgery|April 28, 2005
Differential response to preoperative chemoradiation and surgery in esophageal adenocarcinomas based on presence of Barrett's esophagus and symptomatic gastroesophageal refluxBanke Agarwal, Stephen G Swisher, Jaffer Ajani, et al.
Annals of Surgical Oncology|July 11, 2018
Preoperative Therapy for Gastric Adenocarcinoma is Protective for Poor Oncologic Outcomes in Patients with Complications After GastrectomyDiego Vicente, Naruhiko Ikoma, Yi-Ju Chiang, et al.
American Journal of Clinical Oncology|February 25, 2016
A Phase I/II Study of Docetaxel, Oxaliplatin, and Fluorouracil (D-FOX) Chemotherapy in Patients With Untreated Locally Unresectable or Metastatic Adenocarcinoma of the Stomach and Gastroesophageal JunctionMariela A Blum Murphy, Wei Qiao, Nishith Mewada, et al.
Future Oncology (London, England)|August 24, 2022
HERIZON-GEA-01: Zanidatamab + chemo ± tislelizumab for 1L treatment of HER2-positive gastroesophageal adenocarcinomaJosep Tabernero, Lin Shen, Elena Elimova, et al.
Annals of Surgical Oncology|October 26, 2016
Race Is a Risk for Lymph Node Metastasis in Patients With Gastric CancerNaruhiko Ikoma, Mariela Blum, Yi-Ju Chiang, et al.
Cancer|January 29, 2010
Weekly docetaxel, cisplatin, and 5-fluorouracil as initial therapy for patients with advanced gastric and esophageal cancerMichael J Overman, Syed M Kazmi, Jagriti Jhamb, et al.
International Journal of Radiation Oncology, Biology, Physics|September 5, 2024
Phase 1 Trial of Total Neoadjuvant Therapy With Short-Course Chemoradiotherapy Followed by Chemotherapy for Patients With Potentially Resectable Gastric CancerBrian Badgwell, Naruhiko Ikoma, Mariela Blum Murphy, et al.
Current Medical Research and Opinion|October 17, 2023
Tislelizumab in advanced/metastatic esophageal squamous cell carcinoma: health-related quality of life in Asian patientsSung-Bae Kim, Eric Van Cutsem, Jaffer Ajani, et al.
Pageof 11

Showing results (51-60 of 110) with videos related to

Sort By:
Pageof 11
Annals of Surgical Oncology|March 24, 2017
Patterns of Initial Recurrence in Gastric Adenocarcinoma in the Era of Preoperative TherapyNaruhiko Ikoma, Hsiang-Chun Chen, Xuemei Wang, et al.
International Journal of Radiation Oncology, Biology, Physics|June 16, 2009
Induction and concurrent taxanes enhance both the pulmonary metabolic radiation response and the radiation pneumonitis response in patients with esophagus cancerMatthew McCurdy, Mary Frances McAleer, Wei Wei, et al.
The Annals of Thoracic Surgery|April 28, 2005
Differential response to preoperative chemoradiation and surgery in esophageal adenocarcinomas based on presence of Barrett's esophagus and symptomatic gastroesophageal refluxBanke Agarwal, Stephen G Swisher, Jaffer Ajani, et al.
Annals of Surgical Oncology|July 11, 2018
Preoperative Therapy for Gastric Adenocarcinoma is Protective for Poor Oncologic Outcomes in Patients with Complications After GastrectomyDiego Vicente, Naruhiko Ikoma, Yi-Ju Chiang, et al.
American Journal of Clinical Oncology|February 25, 2016
A Phase I/II Study of Docetaxel, Oxaliplatin, and Fluorouracil (D-FOX) Chemotherapy in Patients With Untreated Locally Unresectable or Metastatic Adenocarcinoma of the Stomach and Gastroesophageal JunctionMariela A Blum Murphy, Wei Qiao, Nishith Mewada, et al.
Future Oncology (London, England)|August 24, 2022
HERIZON-GEA-01: Zanidatamab + chemo ± tislelizumab for 1L treatment of HER2-positive gastroesophageal adenocarcinomaJosep Tabernero, Lin Shen, Elena Elimova, et al.
Annals of Surgical Oncology|October 26, 2016
Race Is a Risk for Lymph Node Metastasis in Patients With Gastric CancerNaruhiko Ikoma, Mariela Blum, Yi-Ju Chiang, et al.
Cancer|January 29, 2010
Weekly docetaxel, cisplatin, and 5-fluorouracil as initial therapy for patients with advanced gastric and esophageal cancerMichael J Overman, Syed M Kazmi, Jagriti Jhamb, et al.
International Journal of Radiation Oncology, Biology, Physics|September 5, 2024
Phase 1 Trial of Total Neoadjuvant Therapy With Short-Course Chemoradiotherapy Followed by Chemotherapy for Patients With Potentially Resectable Gastric CancerBrian Badgwell, Naruhiko Ikoma, Mariela Blum Murphy, et al.
Current Medical Research and Opinion|October 17, 2023
Tislelizumab in advanced/metastatic esophageal squamous cell carcinoma: health-related quality of life in Asian patientsSung-Bae Kim, Eric Van Cutsem, Jaffer Ajani, et al.
Pageof 11